- Notice
Call for Participants [Conference on Transdisciplinary Research] The Future Story of Viruses and Humanity / March 5, 2021, 14:00-@Ota-ku, Tokyo
2021.01.25
A panel discussion titled "The Future Story of Viruses and Humanity: New Insights from the Battle of the Research Field" (session partner: Euglena Co., Ltd.) will be held during the 10th Annual Conference of the Association of Hyperdifferent Fields hosted by LIVANES (March 5-6, 2021 (Friday and Saturday)).
It is precisely because we are experiencing an unprecedented pandemic that we would like to consider the fundamental questions, "Where did viruses come from, who are viruses, and where is humanity going with viruses? As a first step, this session will introduce the origins of viruses, detection and treatment methods that have emerged from front-line research, and discuss how our daily lives and ways of thinking will change in the future. not only COVID-19, but all viruses will continue to change. Therefore, unfortunately, the next outbreak for humanity will also occur at some point. We will extract the future story of viruses and humanity from the perspective of modern science to see how humanity can prepare for that time.
We will have a program of discussions among researchers, start-ups, and large companies from a variety of perspectives, not limited to the themes of this session.
We are now accepting applications for audience participation, poster presentations, and booth exhibitors.The information is available on the convention website (see below).
The Future Story of Viruses and Humanity - New Insights from the Battle in the Research Field
Session Partner: Euglena Co.
Date: Friday, March 5, 2021, 14:00-15:00
Location: Congress Square Haneda (Haneda Innovation City Zone J, 1-1-4 Haneda Airport, Ota-ku, Tokyo)
Details:https://hic.lne.st/conference/hic2021/
speaker
Representative Director, Gene Quest Co.
Executive Officer in charge of Bioinformatics Business, Euglena Co.
Shoko Takahashi
In 2013, while a doctoral student in the Department of Applied Bioscience and Biochemistry, Graduate School of Agricultural and Life Sciences, the University of Tokyo, she started Gene Quest, which aims to promote research on genetic analysis and spread its correct use. 2015, she completed her doctoral studies at the same university. 2018, she became a corporate officer of Euglena Co. Awards received include the Minister of Economy, Trade and Industry Award (Female Entrepreneur Award) at the 2nd Japan Venture Awards by the Ministry of Economy, Trade and Industry, and the Japan Venture Society Award at the Japan BioVenture Awards. She is the author of "Bioscientific Thinking that Transforms the Way You See Business and Life.
Senior Researcher, Custom-Made Medical Research, Inc.
Shuichiro Kashiwaba
Born in Kushiro City, Hokkaido. D. (Engineering) from the Graduate School of Engineering Science, Tokyo University of Science. After receiving his degree, he worked as a postdoctoral researcher at the Institute of Environmental Medicine, Nagoya University, and as an assistant professor at the Faculty of Fundamental Engineering, Tokyo University of Science before assuming his current position in April 2019. He brings his skills and experience in genetic engineering, cell biology, and other areas of expertise to immunology, where he is developing technologies for the efficient production of pharmaceutical-grade antibodies.
Associate Professor, Institute of Medical Science, The University of Tokyo
Kei Sato
Born in Yamagata Prefecture in 1982. Associate Professor, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo. D. in Medicine. D. (3rd year early completion), Graduate School of Medicine, Kyoto University; ECC Yamaguchi Memorial AIDS Research Encouragement Award (Japanese Society for AIDS Research, 2012), Sugiura Encouragement Award (Japanese Society for Virology, 2003), Young Scientist Award, Commendation for Science by the Minister of Education, Culture, Sports, Science and Technology (2008). His research aims to create and pioneer "systems virology," an interdisciplinary research field that integrates virology with molecular phylogenetics, molecular evolution, and bioinformatics.
.
Representative Director, Vice President CTO, Liverness, Inc.
Jyo Inoue
D. in Pharmaceutical Sciences from Tokyo University of Pharmacy and Life Sciences. He is a founding member of LIVERNESS. After completing the doctoral program, he worked as an assistant professor and lecturer at the Faculty of Science, Kitasato University, and as an assistant professor at the Graduate School of Medicine, Kyoto University before becoming a specially-appointed associate professor at the Institute for Advanced Biosciences, Keio University in 2015 and a professor at the Faculty of Pharmaceutical Sciences, Kumamoto University in 2018. While conducting research and development, he is a researcher involved in launching joint research projects with universities and research institutions and supporting the establishment of research institutes.
English 
Japanese